ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.

Philip D Dunne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.